Objectives: To investigate whether modelling techniques can be used in the planning of health care facilities for patients requiring neonatal extracorporeal membrane oxygenation (ECMO).
Introduction
Extracorporeal membrane oxygenation (ECMO) is one of the new technologies in neonatal intensive care. It is a device which is potentially life-saving for neonates with reversible respiratory diseases due to various causes. By temporarily taking over the function of the lungs and heart, ECMO can give diseased lungs the opportunity to recover and can avert the pulmonary complications that frequently occur if prolonged high-pressure ventilation is necessary. However, ECMO itself may induce complications, most notably bleeding due to systemic Bowine anticoagulant treatment.P Therefore, ECMO treatment is generally limited to those who are thought to have a high risk of death with conservative treatment (a predicted survival of 20% or less) and a low risk of complications with ECMO (e.g. a birthweight of 2000 grams or more).H For these patients, ECMO appears to be effective: the Extracorporeal Life Support Organisation (ELSO) reports an overall survival of 80% in 11 000 neonates treated with ECMO,6 and recently, in the UK, the first large prospective randomised controlled trial on ECMO was stopped by the data monitoring committee because patients in the ECMO group showed a much better survival rate than those treated with intensive conservative therapy? Reports on the quality of life after ECMO so far are also favourable. Even though a recently published long-term follow-up study did indicate that ECMO survivors may have an increased risk of behavioural problems and academic difficulties at the age of 5 years compared to patients surviving after conservative treatment," in general, equal or less neurological and psychomotor dysfunction is reported for ECMO survivors than for those managed conservatively.v'? Neonatal ECMO has been introducted differently in various countries. In the USA, ECMO is already an accepted form of therapy for high-risk neonates.P''! In Europe, the introduction of ECMO is on going. Since 1987, ECMO centres have been founded in Germany, France and Sweden among others. 12 • 13 In the UK, ECMO was introduced in the context of a randomised controlled trial. 7 ,14 In The Netherlands, the attitude towards neonatal ECMO has also been cautious. Up to 1995, there were three centres in operation, all waiting for a definite decision on their future status by the health care authorities.
Once the health care authorities in a country approve the use of ECMO, they also have to decide on the number of ECMO facilities that are necessary to provide adequate care. Additionally, in a region where ECMO is already an established therapy it may be necessary to adjust the number of ECMO facilities if changes in the indications for this treatment occur. It is to be expected that the required number of facilities in a region will depend on the number of patients who fulfil the indications for ECMO, the average duration of ECMO treatment and the occurrence of simultaneous patient presentation. Therefore, for any given number of ECMO facilities, momentary over-or under-capacity may occur. Since ECMO is a potentially life-saving treatment, patients who cannot be treated at moments of undercapacity will either have to be treated conservativelywith almost certainly a lower survival probability -or be referred to ECMO centres elsewhere. Whether or not such referrals are feasible and desirable are questions that will not be addressed in this article. Here, we concentrate on the consequences of the establishment of various numbers of ECMO facilities in The Netherlands. The approach followed is generally applicable to any region in any country with the same number of patients requiring ECMO treatment, similar indications and the same distribution of ECMO treatment durations. Additionally, if one of the above variables is different from the Dutch situation, the model can easily be adapted to the local situation.
Methods

Model development
The model describes a process of events after a seriously ill newborn child has been admitted to a Dutch hospital. If the child needs ECMO treatment, and if there are no contraindications, the availability of an ECMO facility is assessed. If an ECMO facility is available the child will be transferred to that facility, otherwise the child will be transferred to a facility abroad ( Fig. 1 ).
In the model, the number of ECMO facilities required to treat various numbers of patients is estimated by simulating ECMO treatments for 1000 separate years and more than 1.8 million individual patients in a discrete event micro-simulation model (Figure 1 ). The micro-simulation model is based on four variables: the number of ECMO facilities; the number of patients First, a baseline analysis is performed, describing the situation in The Netherlands in 1992. Then, several alternative scenarios are formulated to study the effects of plausible future events on the number of ECMO facilities required. Finally, a sensitivity analysis for the main variable, duration of treatment, is performed.
Model estimation
The baseline analysis is based on real data for The Netherlands. In 1992, three ECMO centres were functioning in The Netherlands. Two centres, in Rotterdam and Nijmegen, included patients strictly according to a common research protocol, limiting treatment to neonatal patients with an AaDO, above 600 mmHg for 8 hours, or an Oxygenation Index above 40 in three to five consecutive blood gas samples within 5 hours.
Patients with serious heart disease, causing an important right to left shunting, were excluded. The third facility, in Maastricht, did not follow an official protocol. For this centre, data were only included on the five patients who would have fulfilled the entry criteria used by the other two centres. Patients treated betweenJanuary 1991 and July 1993 were used for the estimation procedure. The main characteristics of these patients are described in Table 1 . The mean treatment duration for these patients was 6 days with a minimum of 0.6 days and a maximum of 15 days. For the model the actual distribution of these times was used to simulate the duration of treatment for each patient. Four hours were added to the duration of treatment, representing the minimum period necessary for cleaning and priming the equipment. Patients were said to be treated simultaneously if any part of their treatment period, including the cleaning period, overlapped with the same period of any other patient.
For each patient the model simulated the date of birth according to the monthly distribution of births in The Netherlands in 1992. 15 Here the assumption was made that ECMO indications themselves showed no separate seasonal trend. As a matter of convenience, the date of birth was used as an approximation of the day of presentation for treatment, because patients were treated with ECMO within an average of 1.9 days (range 0-15 days) after birth.
Results
In the baseline analysis, 29 patients per year are treated in three facilities, as was the situation in The Netherlands in 1992. The model shows that the three facilities will on average be occupied for 58 days per year if patients are evenly spread over the facilities. The other results from the simulations are summarised in the first three columns of Table 2 . The estimates based on the Because ECMO was a new medical treatment facility in The Netherlands, referral policy for this treatment was probably still suboptimal in 1992. Also, it can be expected that inclusion criteria will widen and contraindications will narrow with time. Therefore, the number of treatments per year will probably rise. If the 29 treatments in 1992 are related to the 196734 live births that year," one ECMO treatment per 6784 live births was performed. Estimates based on the ELSO registry tend to a higher rate of ECMO treatments: one in 3859 live births in 1988. 9 Investigators in Georgia, Michigan and Oregon/Washington estimated the need for ECMO in the same magnitude: one in 3717, one in 3431 and one in 3521 births respectively.'t" The need for ECMO in the UK has been estimated at approximately one in 5000 live births.V If these estimates apply to the Dutch situationafter the treatment has become current practice -the number of treatments will rise to 39 (one in 5000 live births) or maybe even to 56 (one in 3500 live births) per year, and, of course, the number of ECMO facilities will have to be adapted to this new situation. In the alternative scenarios account is taken of these changes.
The separate scenarios simulate the effects of a change in the number of neonatal patients annually presenting for treatment, or a change in the number of facilities, or both. It is assumed that there is no change in the average duration of treatment or in the distribution of treatment durations. As may be expected, the number of occasions on which patients require treatment at the same time increases with the number of patients presenting per year. Figure 3 The percentage of patients that will have to be referred to ECMO centres outside the region, if 1-5 facilities are available in the region and 6-60 patients require treatment annually. Figure 2 The number of occasionstwo to six patients will be treated at the same time related to the number of patients requiring treatment annually in a situation with an unlimited number of ECMO facilities. Figure 2 shows that, even if 60 patients fulfil the ECMO criteria annually, there would hardly ever be an occasion on which six patients would need treatment at the same time. However, the assumption that an unlimited number of facilities will be available does not seem realistic. If the number of treatment facilities is limited, some patients will have to be referred to facilities abroad, or be treated conservatively. Depending on the number of facilities and the number of patients requiring treatment annually, it is estimated that between zero and 30 patients will have to be referred to facilities abroad (see Figure 3 ). If only one facility is established while 60 patients present annually, as many as 50% of the patients presenting to that facility will have to be referred abroad. In Figure 4 , the number of occasions on which patients will have to be treated simultaneously is shown for two to 60 patients requiring treatment annually and for two to five ECMO facilities.
Facing an increase to 56 patients annually (one in 3521 births), Dutch health care planners can decide to leave the number of facilities unchanged or expand to four or five facilities. Table 2 shows the consequences of these scenarios. An expansion from three to four facilities will diminish the number of referrals abroad from 3.5 to 0.8 patients on average per year. It is expected that all four facilities would then be occupied at the same time for 4.9 days per year. A further expansion to five facilities decreases the number of referrals abroad even more, to less than one patient in 10 years. The disadvantage of such a policy is that all centres will be occupied simultaneously for only 0.7 days per year.
Sensitivity analysis
If the average duration of ECMO treatment is increased by 1 (16.7%) or 2 days (33.3%) while its distribution remains unchanged, the average number of referrals to centres abroad in the 1992 situation increases to an average of 0.4 patients per year (i.e. a 100% increase) or . +l.5 patients (a 150% increase) (see Table 3 ). However, all changes in the average referrals abroad found in the sensitivity analysis fall within the range of referrals presented in Table 2 .
Discussion
Although the planning of all health care facilities is advisable, the planning of ECMO facilities is particularly important since the patients involved cannot be placed on a waiting list. Patients who cannot be treated because of a shortage in facilities in a region will have to be treated conservatively or be referred to other regions. Planning is necessary not only when ECMO is introduced in a region but also when changes in the number of patients requiring ECMO occur. Such changes, both increases and decreases, could occur through changes in the indications for treatment after publication of the results of randomised trials, through changes in the alternative treatments and through improvements in the technique itself. 14 • 18,19 An increase in the annual number Simulation models in the planning of health care facilities of patients may lead to higher levels of occupancy of the facilities, causing an increase in referrals to facilities outside the region. If the number of ECMO facilities is subsequently increased, the number of patients for whom facilities have to be found outside the area decreases. But, if too many facilities are established, money will be spent on facilities that will be left unoccupied for most of the year. An ECMO facility costs about DFL 300000 (1 DFL = 0.58 US$ = £ 0.38 = 0.47 ECU in June 1996) and initial investments for training of specialised personnel, both physicians and nurses, could amount to over DFL 50000. If an ECMO facility is left unoccupied for a year, the fixed costs for interest, depreciation and maintenance, amounting to roughly DFL 70 000 a year, will still have to be met. If an ECMO facility is only occupied infrequently the salaries of the ECMO personnel will still have to be paid if they cannot be temporarily employed elsewhere. But such temporary employment may cause problems when an ECMO patient arrives unexpectedly for urgent treatment. Also, the existence of spare capacity could lead to a relaxation in the eligibility criteria for ECMO treatment, causing increased use by patients who do not need ECMO to survive, which in turn decreases the cost-effectiveness of the technology. Careful planning of the number of facilities may prevent these effects.
Planning problems in which random processes playa major role, such as the presentation of ECMO patients, can be partially solved by micro-simulation models. Of course, models are abstract representations of reality, and, as stated by Feest and Harrison, they are only as good as the data fed into them. 2o But, although they have their limitations, they provide information that can be used in the planning of health care facilities. Most of the planning in health care with the aid of microsimulation was done for renal services and hospital bed requirernents.i'<" Unfortunately, the results were mainly published in journals specialising in operational research, not read by most health care workers. 13.24.25,27 The micro-simulation model for the planning of ECMO facilities shows that in The Netherlands -if there is no change in the average duration of treatment -an increase to 56 patients a year can take place without an increase in ECMO facilities, ifbetween three and four referrals to centres elsewhere are accepted and feasible. The acceptability or feasibility of these referrals turn out to be crucial points in the planning, because it is not clear who is to decide on these issues. If these referrals are not accepted or are not feasible, an increase in facilities has to be balanced against an investment in facilities which will not be occupied frequently. The model also shows that, even after an increase to 56 patients per
year, the marginal contribution of a fifth facility is very small. Due to the geographical spread of facilities and the patients, the occupancy rate may increase, but this increase will be at the expense of the occupancy rate of the other four facilities.
The current model only includes data on the occupancy of facilities. If reliable data on costs and their relation to the number of patients are available (e.g. the annual number of patients at which additional personnel should be hired and trained, and the number of additional nurses required if patients are treated in two facilities instead of one), the model could be extended to include these data. After such extension, the model could be used to calculate the costs that would have to be incurred to prevent one referral to a centre abroad or outside the region, which would give another dimension to the discussion on the acceptability of referrals abroad. For example, if only fixed costs for interest, depreciation and maintenance are taken into account, setting up a fourth facility in the scenario with 56 patients annually would cost approximately DFL 70 000 annually and would prevent (3.5 -0.8 =) 2.7 referrals abroad ( Table 2 ) at an average cost of (70 000/ 2.7 =) DFL 26000 per prevented referral in interest, depreciation and maintenance of the ECMO equipment only. Costs for additional personnel would have to be added to this.
In countries with large differences in the geographic distribution of patients requiring ECMO treatment due to transport problems, geographically remote areas or unevenness in the incidence of cases, the model cannot be applied to estimate the number of ECMO facilities required on a national level, but it can be used to estimate the need for ECMO facilities in smaller subregions with a homogeneous patient distribution. For The Netherlands, the geographical distributions offacilities and patients are not very important for planning purposes, because it is a small country and newborn babies are relatively easily transported in ambulances and helicopters. In fact, specialised neonatal care in The Netherlands is organised on a national rather than on a regional basis, with a central coordinating system.
The current study shows that the acceptability and feasibility of referrals to centres outside the region -or abroad -is an important issue which European health care planners will have to consider. The study also shows that it is possible to plan the number of ECMO facilities required in a region with relatively simple tools. Such planning may help ECMO centres in their decisions as to whether or not to invest in extra facilities in a Original research changing area of health care. The results of the current study were used by policy-makers in The Netherlands to support their decision to approve the provision of neonatal ECMO in only two ECMO centres. These centres provide a total of three ECMO facilities. For the time being, the government has put no official limit on the number of facilities per centre.
